Correlation Between Crinetics Pharmaceuticals and Viatris

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Crinetics Pharmaceuticals and Viatris at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crinetics Pharmaceuticals and Viatris into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Crinetics Pharmaceuticals and Viatris, you can compare the effects of market volatilities on Crinetics Pharmaceuticals and Viatris and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crinetics Pharmaceuticals with a short position of Viatris. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crinetics Pharmaceuticals and Viatris.

Diversification Opportunities for Crinetics Pharmaceuticals and Viatris

0.51
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Crinetics and Viatris is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Crinetics Pharmaceuticals and Viatris in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viatris and Crinetics Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crinetics Pharmaceuticals are associated (or correlated) with Viatris. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viatris has no effect on the direction of Crinetics Pharmaceuticals i.e., Crinetics Pharmaceuticals and Viatris go up and down completely randomly.

Pair Corralation between Crinetics Pharmaceuticals and Viatris

Given the investment horizon of 90 days Crinetics Pharmaceuticals is expected to generate 11.56 times less return on investment than Viatris. But when comparing it to its historical volatility, Crinetics Pharmaceuticals is 1.35 times less risky than Viatris. It trades about 0.03 of its potential returns per unit of risk. Viatris is currently generating about 0.22 of returns per unit of risk over similar time horizon. If you would invest  1,145  in Viatris on September 3, 2024 and sell it today you would earn a total of  164.00  from holding Viatris or generate 14.32% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Crinetics Pharmaceuticals  vs.  Viatris

 Performance 
       Timeline  
Crinetics Pharmaceuticals 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Crinetics Pharmaceuticals are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Crinetics Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Viatris 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Viatris are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Viatris may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Crinetics Pharmaceuticals and Viatris Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Crinetics Pharmaceuticals and Viatris

The main advantage of trading using opposite Crinetics Pharmaceuticals and Viatris positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crinetics Pharmaceuticals position performs unexpectedly, Viatris can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viatris will offset losses from the drop in Viatris' long position.
The idea behind Crinetics Pharmaceuticals and Viatris pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Equity Valuation
Check real value of public entities based on technical and fundamental data